Duplicate Therapy
Identify possible duplicate therapy for clinical review
Review potential duplication at the active-ingredient, trade-name, and therapeutic-class levels.
Same active ingredient
Identify medication entries that share an active ingredient. Review the formulation and clinical context before deciding what the overlap means for the patient's regimen.
Same trade or brand name
Examine repeated trade-name entries. A repeated entry may call for reconciliation of the medication list, but a screening finding is not itself evidence of inappropriate use.
Same therapeutic class
Review medications within the same therapeutic class. Class overlap can merit attention while still being clinically intentional in a particular regimen.
Duplicate Therapy
RxPedia’s Duplicate Therapy Checker highlights medication entries that share an active ingredient, trade or brand name, or therapeutic class to support medication reconciliation and clinical review.
Consider each finding alongside the formulation and the patient’s clinical context: overlap may be intentional, and a screening finding alone does not establish inappropriate use or a need to change treatment.
Resolve the question through clinical review
Interpret identified duplication alongside treatment intent, medication history, and the information available to the care team. RxPedia does not automatically determine that a combination should be stopped.
Review within the patient profile
Explore duplicate-therapy findings alongside other applicable screening information through Patient Profile Analysis.